ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Mediastinal Staging by Videomediastinoscopy in Clinical N1 Non-Small Cell Lung Cancer: A Prospective Multicentre Study

Thursday, February 1, 2018

Submitted by

Claire Vernon

Source

Source Name: European Respiratory Journal

Source URL: http://erj.ersjournals.com/content/50/6/1701493

Author(s)

Herbert Decaluwé, Christophe Dooms, Xavier Benoit D'Journo, Sergi Call, David Sanchez, Benedikt Haager, Roel Beelen, Volkan Kara, Thomas Klikovits, Clemens Aigner, Kurt Tournoy, Mahmood Zahin, Johnny Moons, Geoffrey Brioude, Juan Carlos Trujillo, Walter Klepetko, Akif Turna, Bernward Passlick, Laureano Molins, Ramon Rami-Porta, Pascal Thomas, Paul De Leyn

Decaluwé and colleagues prospectively tested the capacity of preoperative staging by video-assisted mediastinoscopy (VAM) or VAM-lymphadenectomy (VAM-LA) to detect hidden mediastinal lymph node involvement in patients with non-small cell lung cancer (NSCLC). Of 105 patients with clinical N1 disease based on PET-CT imaging, one quarter eventually developed N2 disease. Patients underwent either VAM or VAM-LA, which were able to detect mediastinal node involvement with a sensitivity of 73% and accuracy of 93%. The authors suggest that VAM or VAM-LA could be a good staging approach for this group of patients.